Scientists in Mainz and Aachen have discovered a new mechanism that controls egg cell fertility and that might have future therapeutic potential. It was revealed by Professor Dr. Walter Stöcker of the Institute of Zoology at Johannes Gutenberg University Mainz (JGU) that the blood protein fetuin-B plays an important and previously unknown role in the fertilization of oocytes.
Oocyte fertilization with and without fetuin-B
Ill.: Walter Stöcker
The role played by the plasma protein fetuin-B was decoded in cooperation with the team in Aachen. The mechanism appears to operate as follows: The oocytes of humans and other mammals are surrounded by a protective envelope called the zona pellucida. This envelope hardens immediately after the successful fertilization of the egg cell by a sperm, which means that subsequent sperm are unable to penetrate the ovum, thus preventing multiple fertilization (polyspermy). Polyspermy results in the death of the embryo in many mammals. The hardening of the zona pellucida is triggered by the proteolytic enzyme ovastacin, the function of which Stöcker's team in Mainz has been investigating. The protease ovastacin is stored in vesicles within the egg cell and when the first sperm penetrates the ovum, the protease is explosively discharged into the gap between the egg cell and the zona pellucida in what is known as the cortical reaction.
However, small amounts of ovastacin continually seep from unfertilized egg cells and this would cause the zona to harden before the first sperm can penetrate. "It is the role of fetuin-B to ensure that these constantly escaping small quantities of ovastacin are inactivated so that oocytes can be fertilized," Stöcker added. "However, once a sperm has penetrated an egg cell, the cortical reaction will be unleashed and the amount of ovastacin will overwhelm the inhibition capacity of fetuin-B and initiate the hardening process."This is the first time that it has been shown that premature hardening of the zona pellucida can be a cause of infertility. It is thus possible that this could represent the basis for the development of future forms of infertility treatment.
Petra Giegerich | idw
Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy